Protection against murine tuberculosis by an attenuated recombinantSalmonella typhimuriumvaccine strain that secretes the 30-kDa antigen ofMycobacterium bovisBCG
Open Access
- 1 April 2000
- journal article
- Published by Oxford University Press (OUP) in FEMS Immunology & Medical Microbiology
- Vol. 27 (4) , 283-289
- https://doi.org/10.1111/j.1574-695x.2000.tb01441.x
Abstract
A recombinant (r-) Salmonella typhimurium aroA vaccine that secretes the naturally secreted protein of Mycobacterium bovis strain BCG, Ag85B, by meansKeywords
This publication has 42 references indexed in Scilit:
- 3.4. Recombinant Bacteria as Vaccine Carriers of Heterologous AntigensPublished by Walter de Gruyter GmbH ,1996
- Development of antigen-delivery systems, based on the Escherichia coli hemolysin secretion pathwayGene, 1996
- Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I‐ and II‐deficient knock‐out mice: contribution of CD4 and CD8 T cells to acquired resistanceEuropean Journal of Immunology, 1995
- Recombinant cytokines for controlling mycobacterial infectionsTrends in Microbiology, 1995
- Lack of Acidification in Mycobacterium Phagosomes Produced by Exclusion of the Vesicular Proton-ATPaseScience, 1994
- Vaccination strategies against intracellular microbesFEMS Immunology & Medical Microbiology, 1993
- Sequestration From Immune CD4 + T Cells of Mycobacteria Growing in Human MacrophagesScience, 1993
- New use of BCG for recombinant vaccinesNature, 1991
- Nucleotide sequence of a plasmid-encoded hemolysin determinant and its comparison with a corresponding chromosomal hemolysin sequenceFEMS Microbiology Letters, 1986
- Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccinesNature, 1981